Bio

I'm a healthcare executive and investor with 20+ years of deal & operating experience at leading global organizations. I've launched products and closed deals which benefit over 9M patients and generate over $20B/yr in revenues today. At present, I invest in the intersection Tech and MedTech and work with emerging health companies as expert board member, advisor and/or executive. My academic interests lie in the area of corporate innovation, with a particular focus on leveraging design thinking and interdisciplinary experience sets to enable actual need-based innovation in complex, global organizations. I'm Faculty at a post-doc program at Stanford Biodesign and have helped select, mentor and graduate 36 Stanford Faculty to-date. Global Product & Commercial Experience: I have led global launches of 6 MedTech products and led a $500M/yr commercial business during 9 years in global marketing leadership roles at Medtronic (Diabetes) and Johnson & Johnson (Ethicon). I launched the world's first real-time continuous glucose monitoring (CGM) products, a category that is now serving over 4M users and generating $10B in revenue . Deal experience: I have diverse transactions experience including 8 equity investments, 2 M&As, 5 partnerships, and a JV deal gained over 10+ years in corporate business development, corporate venture capital, private venture capital, and angel investing. I've worked on major MedTech industry deals including a robotics surgery joint venture (Verb Surgical) between J&J and Alphabet (Verily), the acquisition of Neuwave Medical at J&J, and the structuring of Dexcom Ventures. I'm a lifelong learner and hold a BS in Electrical Engineering with honors from Northwestern University, an MBA from the UCLA Anderson School of Management, and was an Innovation Fellow at Stanford Biodesign.